flow trial semaglutide kidney outcomes hazard ratio 0.76 Effects of With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Disease: A Prespecified Secondary Analysis Kidney and Survival Benefits of

Understanding your weight loss timeline on semaglutide can help set realistic expectations regardless of your dosing schedule

Winnett Specialist Group can help you learn about weight loss medications and explore sustainable weight management care to suit your lifestyle

Semaglutide and Tirzepatide are ideal for individuals struggling with traditional weight loss methods and seeking sustainable solutions

In addition to being a glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide is also a glucose-dependent insulinotropic polypeptide (GIP) receptor

Marc Jean-Gilles, DO, FACOG , at Abundant Life Healthcare offers Semaglutide GLP-1 weight loss injections